Cargando…

Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China

BACKGROUND: The clinical features and factors affecting the prognostic survival of hepatic hydrothorax (HH) are currently unknown. METHODS: We conducted a retrospective cohort study of 131 patients with HH using the Kaplan–Meier method and Cox proportional hazards regression analysis to assess facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bo, Shang, Tianling, Huang, Jianjie, Tu, Zhixin, Wang, Yan, Han, Yujin, Wen, Xiaoyu, Jin, Qinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264701/
https://www.ncbi.nlm.nih.gov/pubmed/35799114
http://dx.doi.org/10.1186/s12876-022-02412-9
_version_ 1784743018456154112
author Ma, Bo
Shang, Tianling
Huang, Jianjie
Tu, Zhixin
Wang, Yan
Han, Yujin
Wen, Xiaoyu
Jin, Qinglong
author_facet Ma, Bo
Shang, Tianling
Huang, Jianjie
Tu, Zhixin
Wang, Yan
Han, Yujin
Wen, Xiaoyu
Jin, Qinglong
author_sort Ma, Bo
collection PubMed
description BACKGROUND: The clinical features and factors affecting the prognostic survival of hepatic hydrothorax (HH) are currently unknown. METHODS: We conducted a retrospective cohort study of 131 patients with HH using the Kaplan–Meier method and Cox proportional hazards regression analysis to assess factors influencing the prognosis of HH. RESULTS: A total of 131 patients were enrolled: the male to female ratio was 80:51 (1.59:1), and the mean age was 52.76 ± 11.88 years. Hepatitis B cirrhosis was the main cause of HH, and abdominal distention and dyspnea were the most common clinical signs. Ascites was present in varying amounts in all patients and was the most common decompensated complication, with pleural effusions mostly seen on the right side (107/131; 82%), followed by the left side (16/131; 12%) and bilateral effusions (8/131; 6%). For overall survival without transplantation, the estimated median survival time was 21 (95% confidence interval [CI]:18–25) months, and survival rates at 6 months, 1 year, and 2 years were 77.2%, 62.4%, and 29.7%, respectively. After controlling for covariates that were associated with liver-related mortality in the univariate analysis, males (hazard ratio [HR]: 1.721, 95% CI: 1.114–2.658, P = 0.005) and combined hepatic encephalopathy (HR: 2.016, 95% CI: 1.101–3.693, P = 0.001) were found to be associated with an increase in liver-related mortality. CONCLUSIONS: In this cohort of HH patients without liver transplantation, male sex and hepatic encephalopathy were associated with a higher risk of liver-related death.
format Online
Article
Text
id pubmed-9264701
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92647012022-07-09 Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China Ma, Bo Shang, Tianling Huang, Jianjie Tu, Zhixin Wang, Yan Han, Yujin Wen, Xiaoyu Jin, Qinglong BMC Gastroenterol Research BACKGROUND: The clinical features and factors affecting the prognostic survival of hepatic hydrothorax (HH) are currently unknown. METHODS: We conducted a retrospective cohort study of 131 patients with HH using the Kaplan–Meier method and Cox proportional hazards regression analysis to assess factors influencing the prognosis of HH. RESULTS: A total of 131 patients were enrolled: the male to female ratio was 80:51 (1.59:1), and the mean age was 52.76 ± 11.88 years. Hepatitis B cirrhosis was the main cause of HH, and abdominal distention and dyspnea were the most common clinical signs. Ascites was present in varying amounts in all patients and was the most common decompensated complication, with pleural effusions mostly seen on the right side (107/131; 82%), followed by the left side (16/131; 12%) and bilateral effusions (8/131; 6%). For overall survival without transplantation, the estimated median survival time was 21 (95% confidence interval [CI]:18–25) months, and survival rates at 6 months, 1 year, and 2 years were 77.2%, 62.4%, and 29.7%, respectively. After controlling for covariates that were associated with liver-related mortality in the univariate analysis, males (hazard ratio [HR]: 1.721, 95% CI: 1.114–2.658, P = 0.005) and combined hepatic encephalopathy (HR: 2.016, 95% CI: 1.101–3.693, P = 0.001) were found to be associated with an increase in liver-related mortality. CONCLUSIONS: In this cohort of HH patients without liver transplantation, male sex and hepatic encephalopathy were associated with a higher risk of liver-related death. BioMed Central 2022-07-07 /pmc/articles/PMC9264701/ /pubmed/35799114 http://dx.doi.org/10.1186/s12876-022-02412-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ma, Bo
Shang, Tianling
Huang, Jianjie
Tu, Zhixin
Wang, Yan
Han, Yujin
Wen, Xiaoyu
Jin, Qinglong
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
title Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
title_full Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
title_fullStr Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
title_full_unstemmed Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
title_short Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China
title_sort analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264701/
https://www.ncbi.nlm.nih.gov/pubmed/35799114
http://dx.doi.org/10.1186/s12876-022-02412-9
work_keys_str_mv AT mabo analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT shangtianling analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT huangjianjie analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT tuzhixin analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT wangyan analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT hanyujin analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT wenxiaoyu analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina
AT jinqinglong analysisofclinicalfeaturesandprognosticfactorsinpatientswithhepatichydrothoraxasinglecenterstudyfromchina